The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 22, 2014

Filed:

Aug. 11, 2011
Applicants:

Jin Sook Kim, Seoul, KR;

Young Sook Kim, Daejeon, KR;

Jung Hyun Kim, Seoul, KR;

Eun Jin Shon, Daejeon, KR;

Ki MO Kim, Daejeon, KR;

Chan-sik Kim, Daejeon, KR;

Dong Ho Jung, Daejeon, KR;

Yun MI Lee, Daejeon, KR;

Kyu Hyung JO, Daejeon, KR;

Ohn Soon Kim, Daejeon, KR;

Nam-hee Yoo, Daejeon, KR;

Inventors:

Jin Sook Kim, Seoul, KR;

Young Sook Kim, Daejeon, KR;

Jung Hyun Kim, Seoul, KR;

Eun Jin Shon, Daejeon, KR;

Ki Mo Kim, Daejeon, KR;

Chan-Sik Kim, Daejeon, KR;

Dong Ho Jung, Daejeon, KR;

Yun Mi Lee, Daejeon, KR;

Kyu Hyung Jo, Daejeon, KR;

Ohn Soon Kim, Daejeon, KR;

Nam-Hee Yoo, Daejeon, KR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 31/14 (2006.01); A61K 31/075 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides a novel biphenyl compound or pharmaceutically acceptable salts thereof, methods for preparing the same, and pharmaceutical compositions for preventing or treating diabetic complications containing the same as an active ingredient. Novel biphenyl compounds, according to the present invention, effectively suppress generation activity of advanced glycation end products, which cause diabetic complications and are a criterion for evaluating the effectiveness of a treating agent for diabetic complications, and show an excellent therapeutic effect on retina blood vessels, increased occludin, and decreased angiogenic growth factor in actual diabetic retinopathy induced retina. Thus, novel biphenyl compounds according to the present invention can be used effectively as an active ingredient in compositions for preventing or treating diabetic complications such as diabetic retinopathy.


Find Patent Forward Citations

Loading…